Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 6, 2014Blood

First-in Man, Phase 1 Study of CSL362 (Anti-IL3Rα / Anti-CD123 Monoclonal Antibody) in Patients with CD123+ Acute Myeloid Leukemia (AML) in CR at High Risk for Early Relapse

View Full Paper
Ask AI
Bookmark
Share

Authors

BSB. Douglas SmithJohns Hopkins UniversityGRGail J. RobozCornell UniversityRWRoland B. WalterCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Smith et al. (2014) studied this question.

synapsesocial.com/papers/6aaa47a2c85bdfeaa654c446https://doi.org/10.1182/blood.v124.21.120.120
View Full Paper
Ask AI
Bookmark
Share